Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:1506

Official publication of the Indian Society of Nephrology
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (360 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded180    
    Comments [Add]    

Recommend this journal


  Table of Contents  
Year : 2017  |  Volume : 27  |  Issue : 3  |  Page : 175-176

Hemodialysis vascular access: The perils and potentials

Department of Renal Medicine, Renal and Transplantation Unit, St. George's University Hospital NHS Foundation Trust, London, UK

Date of Web Publication3-May-2017

Correspondence Address:
D Banerjee
St. George's, University of London, Knightsbridge Wing, Blackshaw Road, Tooting, London SW17 0QT
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0971-4065.196935

Rights and Permissions

How to cite this article:
Banerjee D, Jenkins R. Hemodialysis vascular access: The perils and potentials. Indian J Nephrol 2017;27:175-6

How to cite this URL:
Banerjee D, Jenkins R. Hemodialysis vascular access: The perils and potentials. Indian J Nephrol [serial online] 2017 [cited 2022 Aug 17];27:175-6. Available from:

Vascular access continues to be the “Achilles' heel” for hemodialysis; it causes heightened morbidity and mortality, particularly in incident hemodialysis patients.

Registry data from around the world continue to report poor fistula maturation rates, and the majority of patients are starting dialysis with central venous catheters. In the USA in 2013, 80% of patients started dialysis with a catheter; a figure which has changed very little since 2005.[1] In the UK in 2011, 57% of patients started dialysis with a catheter.[2] Starting dialysis with a catheter is associated with an 8-fold increase in rates of infection requiring prolonged hospital admissions, with a ≤1.4 million spend on methicillin-resistant Staphylococcus aureus infection.[3] A Canadian study reported that the failure of a first fistula was associated with a doubling of the cost of vascular access care in the 1st year of hemodialysis.[3] As the number of dialysis patients increases globally, the extra costs associated with vascular access complications continues to deplete already stretched healthcare resources. In the UK, the Department of Health responded by introducing a financial incentive; providing extra remuneration to dialysis centers for patients dialyzed through a fistula or graft, with a tariff uplift of 33%.[4] In India, the situation is challenging, the number of hemodialysis patients is rising, vascular access is not a priority among hemodialysis providers, and the cost for the patients is huge.[5]

Fistulae created with conventional techniques have poor maturation rates. In a large prospective, randomized controlled trial of antiplatelet therapy, only 40% fistulae were successfully used.[6] In a multinational study, the poor fistula maturation rates resulted in multiple procedures and admissions, and despite this, a large proportion of patients started dialysis with a catheter.[7]

In the study reported in this issue of Indian Journal of Nephrology “Brachio-Cephalic AV Fistula through Median antecubital vein BC-AVF-MAV” is step forward to address and possibly improve the vascular access predicament.[8] The investigators describe a novel technique of using the antecubital fossa veins to create an upper arm fistula. This has several potential advantages; first, it eliminates the need for a second procedure to superficialize the basilic vein; second, it avoids the need for a graft, which has its own disadvantages, and third, it preserves the basilic vein for future use. The results in the 26 patients are encouraging, particularly in a population with a significant proportion being diabetics, with low primary (4%) and secondary (8%) failure rates. However, the technique needs to be tested in larger cohorts, using different surgical groups and perhaps in an older population.

Accurate prediction of fistula maturation has remained difficult. The ultrasound assessment, as used in this study, of the diameter of the vein and artery has been the most popular method but was not shown to be effective in a large randomized trial of antiplatelet therapy.[6] Estimation of blood flow and mapping of local blood vessel using ultrasound and magnetic resonance imaging has been used with limited success.

Endothelial dysfunction predicts intimal hyperplasia and atherosclerosis, which can lead to fistula thrombosis and stenosis. Endothelial function is poor in predialysis and hemodialysis patients and may be a good predictor of fistula outcome. In a small sample endothelial function as measured by brachial artery flow-mediated dilatation was associated with poor outcome.[9]

To improve patient experience, reduce morbidity, and reduce the costs of dialysis; it is essential to develop better methods of patient and vessel selection and prediction of surgical success as well as novel methods of fistula creation, as described in this issue of Indian Journal of Nephrology.

  References Top

United States Renal Data System. 2015 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States; 2015.  Back to cited text no. 1
Fluck R, Pitcher D, Steenkam R. Vascular Access Audit Report 2012; 2012.  Back to cited text no. 2
Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, et al. Establishment and maintenance of vascular access in incident hemodialysis patients: A prospective cost analysis. J Am Soc Nephrol 2005;16:201-9.  Back to cited text no. 3
Department of Health. PbR tariff information spreadsheet for 2012 to 2013, 2013. Available from: pbr-arrangements-for-2012-13. [Last accessed on 2016 May 08].  Back to cited text no. 4
Modi GK, Jha V. The incidence of end-stage renal disease in India: A population-based study. Kidney Int 2006;70:2131-3.  Back to cited text no. 5
Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 2008;299:2164-71.  Back to cited text no. 6
Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008;23:3219-26.  Back to cited text no. 7
Elamurugan E, Hemachandar R. Brachiocephalic arteriovenous fistula for hemodialysis through the median antecubital vein. Indian J Nephrol 2017;27:177-80.  Back to cited text no. 8
  [Full text]  
Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease – A cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011;216:446-51.  Back to cited text no. 9


Print this article  Email this article


Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07